Hepatocellular Cancer Completed Phase 1 Trials for Sorafenib (DB00398)

Also known as: Cancer, Hepatocellular

IndicationStatusPhase
DBCOND0037277 (Hepatocellular Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00997022Trial of Sorafenib in Hepatocellular Cancer (HCC) Transplant PatientsTreatment
NCT02069145Dose Escalation Study of OMP-54F28 in Combination With Sorafenib in Patients With Hepatocellular CancerTreatment